Stoke Therapeutics Chief Executive Edward Kaye Stepping Down
Stoke Therapeutics' chief executive, Edward Kaye, is stepping down after more than seven years at the helm of the biotechnology company. Stoke on Tuesday said Ian Smith, a board member since September ...
Summit Therapeutics names Robert LaCaze as Chief Commercial Officer
Summit Therapeutics (SMMT) “announced that Robert LaCaze has joined Summit Therapeutics as Chief Commercial Officer, reporting to Manmeet S.
The University of Alabama at Birmingham1d
Nugent named senior associate vice president and chief biotechnology and innovation officer
Kathy Nugent, Ph.D., executive director of the University of Alabama at Birmingham ’s Harbert Institute for Innovation and ...
Zacks Investment Research on MSN4d
Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares have added about 7.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Sage moved to Underperform at BofA; says Biogen’s buyout impact has passed
Sage Therapeutics (NASDAQ:SAGE) traded lower for the third straight session on Tuesday after Bank of America moved the ...